SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJourneo Regulatory News (JNEO)

Share Price Information for Journeo (JNEO)

Share Price is delayed by 15 minutes
Get Live Data
440.00    15.00 (3.53%)
Bid:
430.00
Ask:
450.00
Spread: 20.00 (4.651%)
Market Cap: £77.77m
JNEO Live PriceLast checked at - London Stock Exchange

Intraday Journeo Share Chart

AGM Statement

23 May 2006 07:01

TG21 Plc23 May 2006 TG21 plc ("the Group") AGM trading update, business developments and outlook Trading Update At this morning's AGM, the Group intend to make the following statement. Group sales for the first quarter of 2006 were ahead of expectation. Much ofthis increased turnover, however, came from the distribution of low marginportable satellite navigation systems. If the current sales trend continues tothe year end, total budgeted gross profit will be under pressure. Consequently,we have instigated an overhead reduction program in certain targeted areas inthe second quarter. This experience reflects the level of dependence of the legacy elements of ourbusiness on the distribution and installation of in-car entertainment andsecurity products. Our strategy is to move into new growth markets, such aspublic transport CCTV and other areas, where we can add value through theprovision of call centre and engineering logistics services. A number of opportunities in these higher value areas, along with our healthycash flow, have led the Board to conclude that the Group needs to implement acontrolled investment program totalling around £0.5m to exploit these growthopportunities in a timely and effective manner. This will involve therecruitment and training of more engineers to service the new Pay As You Driveinitiative from motor insurers, investment in PDA technology for our engineeringworkforce to streamline our systems and the manufacture, trial and marketing ofour new Revenue-Manager and Eco-Manager products, along with the recruitment ofsales and senior personnel to drive the growth opportunities forward. Business Developments We have announced today that our 75% subsidiary, 21st Century CPS Ltd, hassigned a contract with Biodata Limited for the exclusive rights to their peoplecounting system, when interfaced with public transport vehicle systems.Passenger counting forms a key element of the 21st Century's Revenue-Manageron-board CCTV product. Biodata are also developing an interface to ourEco-Manager product which is aimed at reducing fuel and maintenance costs forbus operators. A major public transport company has already agreed to run trialsof both Revenue-Manager and Eco-Manager on 54 of its buses. In my last Chairman's Statement I highlighted the opportunity for us to provideinstallation services under the new Pay As You Drive ("PAYD") initiatives whicha number of insurance companies are introducing. We have been appointed as aninstallation contractor under Norwich Union's PAYD scheme and contractnegotiations for this project are in their final stages. Outlook By continued tight working capital management, cash flow remains strong withcurrent headroom of over £2.5m on our bank facilities, consequently theexpenditure plans outlined above will be accommodated comfortably within ourexisting financing arrangements. We believe that making the investment this yearwill underpin enduring value for the Group in future years. Peter Ward Chairman Ends For enquiries please contact: Peter Ward Chairman or Wilson Jennings Finance Director 020 8710 4000 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
14th Jul 20217:00 amRNSPreferred Supplier
12th Jul 20217:00 amRNSPurchase Orders
21st Apr 202112:51 pmRNSResult of AGM
25th Mar 20217:00 amRNSFinal Results
17th Mar 20217:00 amRNSNew Purchase Orders
25th Jan 20217:00 amRNSFramework agreement contract extension
22nd Jan 20217:00 amRNSNew purchase orders
14th Dec 20207:00 amRNSTrading Update and Loan Note extension
12th Oct 20207:00 amRNSNew purchase order
14th Sep 20207:00 amRNSHalf-year Report
3rd Aug 20207:00 amRNSFramework Contract Renewal
23rd Jul 20207:00 amRNSReceipt of Purchase Orders and Trading Update
29th Apr 20202:31 pmRNSResult of AGM
15th Apr 20203:21 pmRNSHolding(s) in Company
14th Apr 202011:22 amRNSHolding(s) in Company
3rd Apr 202012:15 pmRNSIssue of Equity
2nd Apr 202012:07 pmRNSGrant of Options and Director/PDMR Shareholding
2nd Apr 20207:00 amRNSFinal Results
27th Feb 20207:00 amRNSTransforming Cities Fund Order
27th Jan 20207:00 amRNSPurchase orders received
7th Jan 20204:15 pmRNSDirector/PDMR Shareholding
3rd Jan 20209:59 amRNSHolding(s) in Company
17th Dec 20193:07 pmRNSHolding(s) in Company
17th Dec 20199:42 amRNSHolding(s) in Company
17th Dec 20198:58 amRNSHolding(s) in Company
10th Dec 20194:39 pmRNSDirector/PDMR Shareholding
10th Dec 201912:39 pmRNSResult of Equity Issue
10th Dec 20197:01 amRNSIssue of Equity
10th Dec 20197:00 amRNSTrading Statement
2nd Dec 201911:33 amRNSResult of Meeting
13th Nov 20197:00 amRNSProposed Share Reorganisation, Change of Name, GM
28th Oct 20197:00 amRNSChange of Adviser
8th Oct 20197:00 amRNSNotification of Contract Award Recommendation
16th Sep 20197:00 amRNSInterim Results
2nd Sep 20197:00 amRNSContract Award
24th Jul 20192:00 pmRNSHolding(s) in Company
22nd Jul 20197:00 amRNSNew Contract Awards with WMCA
22nd May 20197:00 amRNS3-year contract renewal with Arriva UK Bus
24th Apr 20195:20 pmRNSResult of AGM
26th Mar 20197:00 amRNSFinal Results
24th Dec 20187:00 amRNSTrading update and extension of loan note
2nd Nov 20187:00 amRNSExclusive distribution agreement
3rd Sep 20187:00 amRNSInterim Results
21st May 201812:02 pmRNSHolding(s) in Company
25th Apr 201810:47 amRNSResult of AGM & Corporate Presentation
28th Mar 20187:00 amRNSFinal Results
19th Mar 201812:26 pmRNSHolding(s) in Company
16th Mar 20181:30 pmRNSRe: Contract
15th Feb 20187:00 amRNSHolding(s) in Company
21st Dec 20174:00 pmRNSTrading Update and Invoice Discounting Facility

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.